| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9659 | 
      | Human Intestinal Absorption | HIA- | 0.7692 | 
      | Caco-2 Permeability | Caco2- | 0.7205 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5185 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9298 | 
                                                     | Non-inhibitor | 0.9165 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8919 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.3356 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8676 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8203 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5821 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7603 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8303 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8940 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8044 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8436 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9530 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9878 | 
                                                                    | Non-inhibitor | 0.8964 | 
      | AMES Toxicity | Non AMES toxic | 0.6686 | 
      | Carcinogens | Non-carcinogens | 0.8339 | 
      | Fish Toxicity | High FHMT | 0.9576 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.8645 | 
      | Honey Bee Toxicity | Low HBT | 0.6599 | 
      | Biodegradation | Not ready biodegradable | 0.9925 | 
      | Acute Oral Toxicity | IV | 0.6131 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5233 |